FDA provides $14M for orphan drug work; Flagship launches 'pharmaconutrient' developer; Investigators say new method could cure baldness;

@FierceBiotech: ICYMI yesterday: 20 BigPharma and biotech mobile apps - 2013. Report | Follow @FierceBiotech

@JohnCFierce: Good thing we have archives--Pain surges after Pfizer commits to 3rd try for long-delayed pain drug Remoxy. Story | Follow @JohnCFierce

@DamianFierce: It's another Class I recall for CareFusion, and these things are starting to catch up with revenue, it seems. News | Follow @DamianFierce

> The FDA has handed out $14 million in new grants to support the development of new orphan drugs and devices. Release

> Flagship VentureLabs is launching a new company, Pronutria, with a $10.8 million Series A. The company says it plans to build "pharmaconutrients" into a major new class of products. Release

> San Diego-based Arcturus Therapeutics raised a $5 million Series A round to fund its work on RNAi technology. Release

Medical Device News

@FierceMedDev: New special report: Top Med Tech Investments of Q3. Report | Follow @FierceMedDev

@MarkHFierce: For Boston Scientific, the first vaginal mesh implant lawsuits are slated to begin in March. Will the company settle? Item | Follow @MarkHFierce

@MichaelGFierce: Implantable, light-sensitive hydrogel could help treat diabetes. More from FierceDrugDelivery | Follow @MichaelGFierce

> Qiagen inks lung cancer diagnostics deal with Clovis Oncology. Story

> CareFusion's latest malfunction draws FDA's most serious label. Article

> European Parliament advances regs that would strengthen scrutiny of high-risk devices. News

> With FDA nod, Cardiovascular Systems targets $1.5B market. More

Pharma News

@FiercePharma: Two most popular profiles from our Top 10 generics makers report: Teva and Sandoz | Follow @FiercePharma

@CarlyHFierce: Check out the top 10 DTC pharma advertisers from 2013 H1 in the new report. | Follow @CarlyHFierce

> Report: Feds get big 'bang for the buck' in fighting pharma fraud. Story

> Still free from Diovan rivals, Novartis hikes forecast once again. Report

Biotech Research News

@EmilyMFierce:  | Follow @EmilyMFierce

> Harvard, AstraZeneca partner to replace animal testing with 'organs-on-chips.' More

> Takeda, Hopkins developing new pancreatic cancer drugs. Story

> Novartis CDK 4/6 cancer drug effective in preclincal tests, advances to PhI. Item

> New approach could lead to universal flu vaccine. Article

> Mini pancreas grown in lab using mouse cells. Story

Pharma Manufacturing News

@EricPFierce: Is there a connection between pharma DTC spending and job cuts? In some cases, yes. FiercePharma special report | Follow @EricPFierce

> U.K. takes enforcement action against third Wockhardt plant. More

> Authorities seize large load of fake Xanax headed for Egypt. Story

> Teva API plant workers strike over wage gaps. Article

> German contract manufacturers invest €70 million on expansions. Item

> Teva opens $100M Croatia plant as it cuts elsewhere. Report

> Biocad taking biosimilar production to Brazil. More

And Finally… Investigators say they successfully cloned cells found in the scalp and transplanted them onto the backs of mice, pointing to a new way to possibly cure baldness one day. Story

Suggested Articles

Cour unveiled phase 2 data showing that its treatment cut levels of pro-inflammatory cytokines and protected the gut in patients with celiac disease.

Three years after Bayer and gene-editing biotech CRISPR Therapeutics joined forces to launch and run Casebia Therapeutics.

Fresh off Tilos Therapeutics’ $773 million sale to Merck, Barbara Fox is taking the helm of another Cambridge-based company: Rheos Medicines.